Global Dermatological Therapeutics Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

The Psoriasis Segment is Experiencing the Fastest Growth, with North America Emerging as the Largest Regional Market

The Global Dermatological Therapeutics Market, valued at USD 18.45 billion in 2022, is poised for remarkable growth in the forecast period, projected to exhibit an impressive CAGR of 8.33% through 2028. This market is dedicated to the field of dermatological therapeutics, which encompasses the diagnosis, treatment, and management of disorders and conditions affecting the skin, hair, nails, and mucous membranes. Dermatology, as a specialized medical discipline, addresses a diverse spectrum of skin-related issues, spanning common conditions like acne and eczema to intricate disorders such as skin cancer and autoimmune diseases. The core objective of dermatological therapeutics is to provide comprehensive care, encompassing medical, surgical, and cosmetic interventions, all aimed at preserving or enhancing skin health and aesthetics.

Within the realm of dermatological therapeutics, a wide array of treatment modalities comes into play, involving pharmaceutical interventions ranging from topical creams and ointments to oral medications and biologic therapies. These therapeutic strategies are strategically employed to alleviate symptoms, mitigate inflammation, combat infections, and modulate the underlying disease processes.

Numerous compelling factors contribute to the market's growth trajectory. First and foremost, the escalating incidence of skin disorders, including but not limited to acne, psoriasis, eczema, skin cancer, and fungal infections, stands out as a significant driver. This upward trend in skin-related ailments is propelled by several factors, including population aging and the enduring impact of environmental factors on skin health. Consequently, there is a heightened demand for effective treatment options to address these conditions.

Furthermore, an increasing awareness of skincare and a growing preoccupation with aesthetic concerns are reshaping the landscape. This shift in consciousness is largely driven by the pervasive influence of social media, prevailing beauty trends, and a widespread desire for a more youthful appearance. This has translated into elevated demand for dermatological products and procedures, spanning anti-aging treatments and cosmeceuticals.

In tandem with these trends, biotechnology has ushered in an era of innovation. The development of biologic therapies and personalized medicine approaches has paved the way for more targeted and efficacious treatments for various skin conditions, exemplified by advancements in managing conditions like psoriasis and atopic dermatitis.

Moreover, as disposable incomes continue to rise, particularly in emerging markets and among the global middle class, individuals are afforded greater access to dermatological treatments and an extensive array of skincare products.

In summary, the Global Dermatological Therapeutics Market stands at the forefront of skin health, poised to address the pressing need for effective diagnostics, treatments, and care regimens. The market is dynamically shaped by a confluence of factors, including the rising incidence of skin disorders, evolving beauty standards, and innovations in biotechnology, all working together to redefine and enhance the skin health and aesthetic aspirations of individuals worldwide.

Key Market Drivers

Rising Awareness and Aesthetic Concerns

Aesthetic concerns related to aging, such as fine lines, wrinkles, and age spots, drive the demand for anti-aging dermatological products and procedures. This includes the use of topical creams, injectables like Botox, and laser treatments. Many individuals seek dermal fillers to enhance facial volume and achieve a more youthful appearance. These treatments often fall under the domain of dermatological therapeutics. Chemical peels are used for skin rejuvenation, improving skin texture, and addressing aesthetic concerns like pigmentation irregularities. Aesthetic concerns about scars, whether from surgery, acne, or injuries, lead to the demand for scar management products and treatments. The desire for brighter and more even-toned skin has driven the market for dermatological products that address issues such as hyperpigmentation and melasma. Acne is a common skin condition that can lead to aesthetic concerns, especially when it results in scarring. Dermatological therapeutics, including prescription and over-the-counter products, are sought after for acne management and scar reduction.

Increasing awareness of the damaging effects of UV radiation and the importance of sun protection has led to greater use of dermatological products like sunscreens and skin cancer prevention therapies. The influence of social media, beauty influencers, and celebrity endorsements has made people more conscious of their appearance and skincare routines. This has contributed to the demand for a wide range of dermatological products. Consumers have access to more information than ever before, allowing them to educate themselves about skincare and the benefits of dermatological products. This education often leads to increased product adoption. Dermatological therapeutics have become more personalized to meet individual skincare needs. Customized skincare regimens, often recommended by dermatologists, have gained popularity. The preference for minimally invasive aesthetic procedures, such as laser therapy and microdermabrasion, has grown due to reduced downtime and natural-looking results. Celebrities openly discussing their skincare routines and endorsements of specific products or treatments can significantly influence consumer choices and boost demand. The globalization of beauty ideals, where clear and healthy skin is considered universally attractive, has led to the global demand for dermatological products and treatments. This factor will help in the development of Global Dermatological Therapeutics Market.

Advancements in Biotechnology

Biotechnology has led to the development of innovative and targeted treatments for various skin conditions. Biotechnology has enabled the creation of biologic drugs for dermatological conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa. These drugs, often monoclonal antibodies, target specific molecules in the immune system or inflammatory pathways, providing more precise and effective treatments with fewer side effects. Biotechnological advancements have facilitated personalized medicine in dermatology. Genetic testing and biomarker analysis allow dermatologists to tailor treatments to an individual's genetic makeup and disease characteristics, enhancing treatment efficacy and safety. Biotechnology has led to the development of advanced drug delivery systems, such as nanoparticles and liposomes, which enhance the penetration of therapeutic agents into the skin. This innovation improves the effectiveness of topical dermatological treatments. Biotechnology has given rise to regenerative medicine approaches in dermatology. Stem cell therapy and tissue engineering hold promise for repairing damaged skin and treating conditions like chronic wounds and scars. Biotechnological tools, including genetic sequencing and molecular diagnostics, enable more precise and early diagnosis of dermatological conditions. Timely and accurate diagnosis drives the demand for appropriate therapeutics. Biotechnology has led to the development of biocompatible and bioresorbable materials used in dermatological treatments, such as dermal fillers and sutures, for aesthetic and reconstructive purposes.

Biotechnology has improved the ability to culture skin cells and tissues in the laboratory. This facilitates research, drug testing, and the development of novel dermatological therapies. Ongoing research in gene therapy holds promise for treating genetic skin disorders by correcting or replacing faulty genes. Although in its early stages, gene therapy has the potential to revolutionize dermatological therapeutics. Advances in biotechnology have expanded the use of immunotherapy for skin cancer treatment. Immune checkpoint inhibitors and other immunotherapeutic agents have shown efficacy in treating melanoma and other skin cancers. Biotechnology has enabled the development of biology for rare dermatological conditions, addressing previously unmet medical needs and increasing access to effective treatments. Biotech companies invest heavily in dermatological research and development, leading to a pipeline of innovative products and therapies that drive the market forward. This factor will pace up the demand of Global Dermatological Therapeutics Market.

Increase in Disposable Income

With higher disposable income, individuals are more willing and able to invest in premium skincare products. This includes high-end moisturizers, serums, and specialty creams, which are often considered part of dermatological skincare. An increase in disposable income allows individuals to afford cosmeceutical products that bridge the gap between cosmetics and pharmaceuticals. Additionally, people may opt for aesthetic dermatological treatments, such as chemical peels, microdermabrasion, and laser therapy, which can be costly but provide visible results. Higher income levels often mean better access to dermatologists and skincare specialists. People can seek professional advice and receive personalized treatment plans, including prescription dermatological therapeutics, when necessary. Affluent individuals may choose to undergo advanced dermatological procedures like Botox injections, dermal fillers, and laser resurfacing to address aging concerns and skin imperfections.

People with higher disposable income may be more inclined to invest in high-quality sunscreens and sun-protective clothing to prevent sun damage and reduce the risk of skin cancer. Individuals with higher incomes can afford long-term treatment regimens for chronic skin conditions such as psoriasis, eczema, and acne, including prescription medications and biologic therapies. Rising income levels often lead to the adoption of holistic skincare routines that encompass a range of dermatological therapeutics, including cleansers, moisturizers, and specialty treatments. The ability to afford preventive and anti-aging dermatological products allows individuals to proactively address skin concerns, maintain youthful skin, and prevent the progression of skin conditions. People with higher disposable incomes may travel to seek dermatological treatments or aesthetic procedures in countries known for their advanced medical facilities and expertise. Medical spas offering a combination of clinical skincare treatments and relaxation services are popular among individuals with disposable income, driving demand for various dermatological procedures. Some affluent consumers prefer customized and boutique skincare solutions, including personalized skincare formulations tailored to their specific needs. Higher-income individuals may be drawn to luxury skincare brands that offer exclusive and premium dermatological products. This factor will accelerate the demand of Global Dermatological Therapeutics Market.

Key Market Challenges

Generic Competition

When generic versions of dermatological drugs become available, they are often sold at significantly lower prices than their branded counterparts. This can lead to price erosion for the branded products, reducing their market share and profitability. Branded dermatological products typically have patent protection for a certain period, during which they enjoy exclusivity in the market. When these patents expire, generic manufacturers can enter the market with lower-cost alternatives, reducing the market share of the original brand. The introduction of generic versions of dermatological drugs can result in a sharp decline in sales revenue for the pharmaceutical companies that developed and marketed the branded products. Generic competition can intensify competition within the dermatological therapeutics market, which can, in turn, lead to pricing pressures and reduced profit margins for both branded and generic manufacturers. As more generic versions of a dermatological drug become available, the market can become fragmented, with multiple manufacturers offering similar products. This fragmentation can make it challenging for dermatologists and patients to choose among various generic options. Healthcare providers, including dermatologists, may increasingly prescribe generic dermatological drugs to reduce healthcare costs. This can lead to a decline in the use of branded products.

Market Saturation

When multiple companies offer similar dermatological products for the same conditions, competition can become intense. This competition may lead to price wars, reducing profit margins for all players. With a saturated market, companies may lower prices to gain a competitive edge, which can result in reduced overall revenue and profitability. In a saturated market, it becomes increasingly difficult for companies to capture additional market share, as most potential customers are already using existing products. When numerous products treat the same dermatological conditions, it can be challenging for companies to differentiate their offerings based on efficacy or other factors. Market saturation can discourage investment in research and development for new dermatological therapies, as companies may perceive limited opportunities for significant returns on investment. Rather than developing groundbreaking treatments, companies may focus on making incremental improvements to existing products to maintain market share. Established brands may have an advantage in saturated markets due to existing customer loyalty, making it harder for newer entrants to gain traction.

Key Market Trends

Personalized Medicine

Advances in genetics and genomics have allowed dermatologists to analyze a patient's genetic profile to better understand their susceptibility to certain skin conditions or their response to specific treatments. Genetic testing can help identify genetic markers associated with conditions like psoriasis or melanoma, enabling personalized treatment plans. Dermatologists are increasingly using biomarkers, which are specific molecules or genetic markers found in a patient's skin or blood, to assess the severity of skin conditions and predict their response to certain therapies. This helps tailor treatment approaches for better outcomes. With a deeper understanding of the molecular mechanisms underlying skin disorders, dermatologists can prescribe targeted therapies, including biologics and small molecule inhibitors, that specifically address the pathways contributing to a patient's condition. This approach minimizes side effects and maximizes treatment efficacy. Compounded topical treatments can be personalized to suit an individual's skin type, condition, and sensitivities. Dermatologists may work with compounding pharmacists to create customized formulations tailored to the patient's needs. Personalized medicine allows dermatologists to identify individuals at higher risk of skin cancers or other dermatological conditions. This enables more proactive surveillance and preventive measures, such as regular skin cancer screenings or tailored skincare routines.

Segmental Insights

Drug Class Insights

In 2022, the Global Dermatological Therapeutics Market largest share was held by Anti-infectives segment in the forecast period and is predicted to continue expanding over the coming years. Skin infections, including bacterial, fungal, and viral infections, are common dermatological conditions worldwide. These infections can range from minor to severe and require medical treatment. As a result, there is a consistent demand for anti-infective dermatological therapeutics. Acne is a widespread skin condition often caused or exacerbated by bacterial infection. Acne treatments, including topical and oral antibiotics, fall under the anti-infectives category and have been widely prescribed. Certain viral skin infections, such as herpes simplex and shingles (herpes zoster), require antiviral medications as part of their treatment.

Application Insights

In 2022, the Global Dermatological Therapeutics Market largest share was held by Psoriasis segment and is predicted to continue expanding over the coming years. Chronic autoimmune skin disease called psoriasis quickens the development cycle of skin cells. On the elbows, face, palms, knees, scalp, lower back, and soles of feet, it results in regions of thickly red skin with silvery scales. Plaque psoriasis, the most prevalent kind, is brought on by mistaken T-cell attacks on the skin. The segment's growth is anticipated to be aided by the rising prevalence of psoriasis, the rising number of clinical trials for psoriasis drug development, and the rising advances by key market participants.

Regional Insights

The North America region dominates the Global Dermatological Therapeutics Market in 2022. North America boasts a well-developed healthcare infrastructure, including many dermatology clinics and healthcare providers specializing in skin disorders. North America is home to many leading pharmaceutical companies and research institutions that invest heavily in dermatological research and product development. This region often leads in the development of new therapies and treatments. Skin conditions like acne, psoriasis, eczema, and skin cancer are prevalent in North America, contributing to the demand for dermatological therapeutics.

Key Market Players

• Abbvie Inc. (Allergan PLC)
• Almirall SA
• Amgen Inc.
• Bausch Health Companies Inc.
• Galderma SA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Bristol-Myers Squibb Company

Report Scope

In this report, the Global Dermatological Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatological Therapeutics Market, by Application:

• Alopecia
• Herpes
• Psoriasis
• Rosacea
• Atopic Dermatitis
• Other Applications

Dermatological Therapeutics Market, by Drug Class:

• Anti-infectives
• Corticosteroids
• Anti-acne
• Calcineurin Inhibitors
• Retinoids
• Other Drug Classes

Dermatological Therapeutics Market, by region:

• North America
• Asia-Pacific
• Europe
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatological Therapeutics Market.

Available Customizations

The following customization option is available based on your specific needs: Detailed analysis and profiling of additional market players (up to five).


This product will be delivered within 1-3 business days.